Is Cyclacel Pharmaceuticals Inc (CYCC) Stock at the Top of the Biotechnology Industry?

The 44 rating InvestorsObserver gives to Cyclacel Pharmaceuticals Inc (CYCC) stock puts it near the middle of the Biotechnology industry. In addition to scoring higher than 38 percent of stocks in the Biotechnology industry, CYCC’s 44 overall rating means the stock scores better than 44 percent of all stocks.

CYCC has an Overall Score of 44. Find out what this means to you and get the rest of the rankings on CYCC!

See Full CYCC Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Cyclacel Pharmaceuticals Inc Stock Today?

Cyclacel Pharmaceuticals Inc (CYCC) stock is trading at $2.16 as of 10:13 AM on Monday, Apr 1, an increase of $0.05, or 2.37% from the previous closing price of $2.11. The stock has traded between $2.16 and $2.23 so far today. Volume today is light. So far 4,819 shares have traded compared to average volume of 37,953 shares. Click Here to get the full Stock Report for Cyclacel Pharmaceuticals Inc stock.